US Molecular Diagnostics Market Studied by IGATE Research in New Cutting-edge Report Available at MarketPublishers.com21 Oct 2015 • by Natalie Aster
LONDON – In the US molecular diagnostic market, infectious diseases control the lion’s share of the market. Molecular oncology tests have become an important fast growing segment of the market. Surging public awareness of the connection between health and genes has driven up the demand for molecular genetic testing. The genetic testing is the 3rd largest market segment, with the blood screening test segment following after. Molecular diagnostics is also growing in popularity as a key tool for human leukocyte antigen (HLA) testing, food pathogen detection testing and other areas of diseases.
Increasing automation, investments in proteomics and genomics research, the rise of personalized medicine, amid others, are driving the growth of the US molecular diagnostics market. Meantime, a set to factors such as regulatory issues; reimbursement capabilities; quality checkpoints, awareness and acceptance are hindering the sector’s development.
Hologic Inc. grabs the maximum share of the US molecular diagnostics market, followed by Myriad Genetics and Roche ranking second and third, respectively. In 2014, molecular diagnostics captured 50% of Qiagen’s overall sales. In 2015, Cepheid is expected to extend the market segment reach by entering the CLIA waived test market in the United States.
New research report “United States - Molecular Diagnostics Market, Test Volume and Company Analysis to 2020” developed by iGATE Research Pvt. Ltd. presents a unique guide to the US molecular diagnostics market. It provides an in-depth analysis of the market along with offering detailed market forecasts; provides test volumes and forecasts; covers molecular diagnostics market share and forecast by application and by company; presents US molecular diagnostics test volume share and forecast by application. Additionally, the study offers an all-encompassing analysis of the domestic companies including their sales, along with the drivers and challenges of the US molecular diagnostics marketplace.
United States - Molecular Diagnostics Market, Test Volume and Company Analysis to 2020
Published: October, 2015
Price: US$ 1,250.00
More studies can be found at iGATE Research page.